Florian Krammer Selected Research

Influenza Vaccines (Influenza Vaccine)

12/2021	Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors.
10/2021	Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.
1/2021	Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.
1/2021	Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*.
12/2020	Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses.
12/2020	Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.
1/2020	Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.
1/2020	Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses.
1/2020	Analysis of the vaccine-induced influenza B virus hemagglutinin-specific antibody dependent cellular cytotoxicity response.
1/2020	Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Florian Krammer Research Topics

Disease

124	Infections 11/2022 - 07/2010
88	Human Influenza (Influenza) 11/2022 - 01/2010
72	COVID-19 06/2022 - 01/2020
12	Virus Diseases (Viral Diseases) 12/2021 - 07/2013
12	Influenza in Birds (Avian Flu) 01/2021 - 01/2013
9	Inflammation (Inflammations) 01/2022 - 07/2020
7	Vesicular Stomatitis 10/2021 - 03/2015
6	Pneumonia (Pneumonitis) 02/2022 - 01/2017
5	Weight Loss (Weight Reduction) 02/2022 - 01/2017
5	Zika Virus Infection 10/2020 - 01/2017
4	Neoplasms (Cancer) 01/2022 - 01/2018
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2022 - 12/2019
3	Breakthrough Infections 02/2022 - 08/2021
3	Respiratory Tract Infections (Respiratory Tract Infection) 02/2021 - 01/2021
3	Orthomyxoviridae Infections 09/2018 - 10/2012
2	Convalescence 04/2022 - 11/2021
2	Disease Progression 11/2021 - 11/2020
2	Fever (Fevers) 03/2021 - 05/2018
2	Diarrhea 01/2021 - 12/2020
2	Severe Dengue 10/2020 - 04/2020
2	Vaccinia 07/2020 - 01/2019
2	Zoonoses 01/2018 - 01/2018
1	Multiple Sclerosis 06/2022
1	Premature Birth (Birth, Premature) 01/2022
1	Reinfection 01/2022
1	Headache (Headaches) 01/2022
1	Fatigue 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Myalgia 01/2022
1	Pain (Aches) 01/2022
1	Measles 12/2021
1	Lung Injury 03/2021
1	Multiple Myeloma 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2021

Drug/Important Bio-Agent (IBA)

114	VaccinesIBA 06/2022 - 01/2010
81	AntibodiesIBA 11/2022 - 02/2012
66	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 01/2010
44	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021 - 07/2010
36	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2010
26	Neuraminidase (Sialidase)IBA 11/2022 - 01/2013
22	EpitopesIBA 11/2022 - 07/2010
21	Neutralizing AntibodiesIBA 12/2021 - 02/2012
20	Immunoglobulin G (IgG)IBA 01/2022 - 07/2013
18	AntigensIBA 01/2022 - 04/2014
15	Monoclonal AntibodiesIBA 12/2021 - 06/2012
12	Glycoproteins (Glycoprotein)IBA 03/2021 - 06/2014
11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2017
9	Immunoglobulin A (IgA)IBA 12/2021 - 07/2013
8	CytokinesIBA 01/2022 - 01/2016
8	Membrane Glycoproteins (Membrane Glycoprotein)IBA 04/2021 - 03/2015
5	Peptides (Polypeptides)IBA 11/2022 - 01/2016
5	mRNA VaccinesIBA 02/2022 - 10/2020
5	ImmunosorbentsIBA 01/2022 - 01/2017
5	COVID-19 VaccinesIBA 01/2022 - 07/2020
5	EnzymesIBA 01/2022 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Messenger RNA (mRNA)IBA 02/2022 - 01/2018
4	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2012
4	NucleoproteinsIBA 01/2021 - 01/2019
4	Viral HemagglutininsIBA 01/2019 - 10/2012
3	Immune Sera (Antisera)IBA 01/2022 - 01/2016
3	ChemokinesIBA 01/2022 - 01/2020
3	Immunoglobulin M (IgM)IBA 08/2021 - 07/2020
3	SARS-CoV-2 spike proteinIBA 01/2021 - 11/2020
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 12/2020
3	Combined VaccinesIBA 01/2021 - 12/2016
2	BNT162 VaccineIBA 04/2022 - 05/2021
2	sinovac COVID-19 vaccineIBA 04/2022 - 05/2021
2	Formaldehyde (Formol)FDA Link 01/2022 - 10/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 08/2021
2	Ad26COVS1IBA 11/2021 - 01/2021
2	LipidsIBA 07/2021 - 01/2021
2	ChAdOx1 nCoV-19IBA 01/2021 - 01/2021
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 01/2016
2	poly(oxyethylene) cholesteryl etherIBA 01/2021 - 10/2020
2	Viral AntigensIBA 01/2021 - 09/2020
2	Viral RNAIBA 01/2021 - 12/2020
2	Viral VaccinesIBA 01/2021 - 01/2019
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 12/2020
2	Nucleocapsid ProteinsIBA 01/2021 - 09/2020
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 12/2020
2	NucleosidesIBA 10/2020 - 01/2018
2	Inactivated VaccinesIBA 01/2020 - 01/2017
2	Oseltamivir (Tamiflu)FDA Link 01/2017 - 01/2013
2	Broadly Neutralizing AntibodiesIBA 12/2015 - 09/2014
2	Indicators and Reagents (Reagents)IBA 04/2014 - 02/2012
1	Complement System Proteins (Complement)IBA 01/2022
1	ParaffinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 12/2021
1	PhosphoproteinsIBA 12/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021
1	NDV-HXP-S COVID-19 vaccineIBA 10/2021
1	nasIBA 10/2021
1	remdesivirIBA 08/2021
1	Ligases (Synthetase)IBA 01/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2022 - 08/2021
2	Immunotherapy 01/2021 - 01/2020
1	Immunomodulation 06/2022
1	Length of Stay 01/2022